UK-based Mycofeast has announced an agreement to acquire New Zealand company Daisy Lab, according to Dealroom. The transaction is a biotech deal between the two companies.
The deal stage is announced, meaning the acquisition has not yet been completed. The financial amount was not disclosed in the sources, and no purchase price or other terms were reported.
No further details on the transaction, including its rationale, timing, or structure, were provided in the available source material.